Contact
Please use this form to send email to PR contact of this press release:
Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials
TO:
Please use this form to send email to PR contact of this press release:
Cristal Therapeutics Awarded €2.5 Million Horizon 2020 Grant to Advance Its CriPec®-docetaxel Through Phase 2 Trials
TO: